• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Extracellular matrix protein FRAS1 (FRAS1), Truncated

ACP15613

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP15613 Target NameFRAS1
Target SynonymsExtracellular matrix protein FRAS1; Fras 1; Fras1; FRAS1_HUMAN; Fraser syndrome 1FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ86XX4
Background Information
  • Uniprot Id

    Q86XX4

  • Target Species

    Human

  • Target Name

    FRAS1

  • Target Full Name

    Extracellular matrix organizing protein FRAS1

  • Target Function

    Involved in extracellular matrix organization. Required for the regulation of epidermal-basement membrane adhesion responsible for proper organogenesis during embryonic development. Involved in brain organization and function.

  • Target Involvement

    Fraser syndrome 1 (FRASRS1)

  • Target Subcellular Location

    Cell membrane; Single-pass type I membrane protein; Extracellular side.

  • Target Protein Families

    FRAS1 family

  • Target Tissue Specificity

    Expressed in many adult tissues, with highest levels in kidney, pancreas and thalamus. Relatively high expression was also detected in fetal kidney and heart.

  • Target Synonyms

    Extracellular matrix protein FRAS1; Fras 1; Fras1; FRAS1_HUMAN; Fraser syndrome 1

Inquire Recombinant Human Extracellular matrix protein FRAS1 (FRAS1), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification